Regulus Therapeutics (RGLS) Q4 2023 Earnings

Mar 21Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.44
-0.42
-0.39
-0.37

Details

Expected EPS
-0.39
Actual EPS
-0.4
Surprise EPS
-0.01
Surprise Percent
-2.56%

Description

⁨Regulus Therapeutics⁩ (⁦RGLS⁩) has reported earnings of ⁦-0.4⁩ per share for ⁦Q4 2023⁩.

0 Comments

Share your thoughts